Showing 2061-2070 of 18601 results for "".
New Research Suggests Increased Number of IVF Cycles Can Be Beneficial
https://reachmd.com/programs/the-jama-report/new-research-suggests-increased-number-ivf-cycles-can-be-beneficial/7864/[Read the Article] Women facing infertility often turn to in vitro fertilization (IVF). Although IVF technology has improved, there is still a widely held belief that if a woman doesn't experience a successful live birth after three or four IVF cycles, her chances of a successful live birth are veryProteinuria in CKD Progression: Understanding Its Role and Monitoring Strategies
https://reachmd.com/programs/clinicians-roundtable/proteinuria-in-ckd-progression-understanding-its-role-and-monitoring-strategies/37216/Not only can proteinuria be a predictor of chronic kidney disease (CKD) progression, but it can also contribute to that progression and kidney damage. That’s why it’s imperative that we monitor proteinuria levels in our patients and take the appropriate steps to reduce it. To learn more about proteiEarly Antibiotic Use May Halt Progression of Severe Respiratory Illness in Young Children
https://reachmd.com/programs/the-jama-report/early-antibiotic-use-may-halt-progression-severe-respiratory-illness-young-children/7768/[Read the Article] Preschool children who experience repeated episodes of severe lower respiratory tract infections (LRTI) often present with symptoms like wheezing and difficulty breathing. A new study looked at whether the use of the common antibiotic, azithromycin, would help prevent progressionDeciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
https://reachmd.com/programs/clinicians-roundtable/deciphering-the-link-proteinuria-and-egfr-dynamics-in-igan-and-fsgs/37215/High levels of proteinuria are associated with a high risk of kidney failure in the future, both for IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). In fact, proteinuria levels can help predict disease progression, outcomes, and even optimal therapeutic approaches. Joining Dr.CLL17 Trial Insights: Fixed-Duration vs Continuous Therapy in Frontline CLL
https://reachmd.com/programs/project-oncology/cll17-trial-fixed-continuous-therapy-frontline-cll/39975/At the 2025 American Society of Hematology Annual Meeting and Exposition, researchers presented key findings from the pivotal phase three CLL17 trial, which was the first randomized study to directly compare continuous BTK inhibition with fixed-duration venetoclax-based therapy in previously untrModernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice
https://reachmd.com/programs/project-oncology/modernizing-pulmonary-assessment-reassessing-race-neutral-interpretation-in-practice/39036/As medicine shifts toward race-neutral lung function interpretation, new challenges emerge in ensuring equitable access to care. Dr. Ajay Sheshadri explores how race-neutral spirometry may impact patient selection for lung resection surgery and hematopoietic cell transplantation. Dr. SheshadrEasing the Perimenopause Transition with IUDs: Key Clinical Considerations
https://reachmd.com/programs/advances-in-womens-health/easing-the-perimenopause-transition-with-iuds-key-clinical-considerations/36132/An IUD can do more than provide contraception in midlife. For patients in their 40s, progestin-containing IUDs can help manage a range of perimenopausal symptoms, like abnormal bleeding, hormonal fluctuations, hot flashes, and cycle irregularity. Joining Dr. Brian McDonough to explore the role of IUDiagnosing and Treating Primary Biliary Cholangitis: Key Clinical Insights
https://reachmd.com/programs/gi-insights/diagnosing-and-treating-primary-biliary-cholangitis-key-clinical-insights/29157/Tune in to learn how we can improve the diagnosis and treatment of primary biliary cholangitis.Navigating Iron Deficiency Anemia: A Practical Guide for Gastroenterologists
https://reachmd.com/programs/gi-insights/program-name/36501/Iron deficiency anemia is common in gastroenterology patients and is often underrecognized or suboptimally managed. That's why targeted treatment is essential to improve patient outcomes. In this expert-led discussion, Dr. Peter Buch and Dr. Thomas DeLoughery outline what gastroenterologists need tTreating Psoriasis Patients Who Vape: Barriers and Interventions
https://reachmd.com/programs/clinicians-roundtable/treating-psoriasis-patients-who-vape-barriers-and-interventions/36368/For dermatologists, treating psoriasis patients who use e-cigarettes can be challenging, particularly because of a lack of education about its risks, mental health concerns, and impacts on treatment efficacy. That being said, there are ways to address these challenges to support patients and improve